Published in Cancer on September 01, 1980
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. Neuro Oncol (2015) 2.21
Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas. Neuro Oncol (2006) 1.76
Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods. Neuro Oncol (2006) 1.50
When progressive disease does not mean treatment failure: reconsidering the criteria for progression. J Natl Cancer Inst (2012) 1.28
Exploring intra- and inter-reader variability in uni-dimensional, bi-dimensional, and volumetric measurements of solid tumors on CT scans reconstructed at different slice intervals. Eur J Radiol (2013) 1.17
Accuracy of computerized tomography in determining hepatic tumor size in patients receiving liver transplantation or resection. J Clin Oncol (1984) 1.13
Surrogate endpoints. Br J Cancer (1993) 0.93
Reproducibility of linear tumor measurements using PACS: comparison of caliper method with edge-tracing method. Eur Radiol (2003) 0.92
Emerging techniques and technologies in brain tumor imaging. Neuro Oncol (2014) 0.86
Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials. Neurotherapeutics (2017) 0.78
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg (1996) 2.20
Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg (1992) 2.10
A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys. Int J Obes Relat Metab Disord (2001) 2.03
Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinoma. Lancet (1990) 1.94
Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol (1988) 1.92
Rates of urinary tract injury from gynecologic surgery and the role of intraoperative cystoscopy. Obstet Gynecol (2006) 1.84
A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol (1983) 1.67
Uveal malignant melanoma associated with ocular and oculodermal melanocytosis. Ophthalmology (1982) 1.51
An alternative model for the evaluation of antitumor activity. Cancer Clin Trials (1981) 1.49
Variations in physicians' hospitalization practices: a population-based study in Manitoba, Canada. Am J Public Health (1986) 1.49
The effectiveness of one-on-one nurse education on the outcomes of high-risk adult and pediatric patients with asthma. Manag Care Interface (1998) 1.46
A simplified protocol for pessary management. Obstet Gynecol (1997) 1.46
Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. J Clin Oncol (1984) 1.44
The effect of aspartame as part of a multidisciplinary weight-control program on short- and long-term control of body weight. Am J Clin Nutr (1997) 1.35
A multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200, a new cross-linked formulation of hyaluronic acid, to phosphate buffered saline for treatment of osteoarthritis of the knee. Osteoarthritis Cartilage (2012) 1.28
Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275). Cancer (1985) 1.23
An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277). J Clin Oncol (1984) 1.20
Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group. Clin Orthop Relat Res (2001) 1.19
CA 125 for the monitoring of ovarian carcinoma during primary therapy. Obstet Gynecol (1987) 1.19
Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med (1980) 1.19
Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease. Am J Obstet Gynecol (1988) 1.16
Absolute granulocyte, lymphocyte, and moncyte counts. Useful determinants of prognosis for patients with metastatic cancer of the stomach. JAMA (1982) 1.14
Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma. Gynecol Oncol (1989) 1.11
Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses. Obstet Gynecol (1988) 1.10
Ovarian clear cell carcinoma. A clinicopathologic analysis of 44 cases. Int J Gynecol Pathol (1989) 1.10
Baseline characteristics of patients enrolled in the Canadian Fabry Disease Initiative. Mol Genet Metab (2009) 1.08
The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer. Am J Obstet Gynecol (1986) 1.06
The efficacy and tolerability of famotidine and ranitidine on the healing of active duodenal ulcer and during six-month maintenance treatment, with special reference to NSAID/aspirin-related ulcers. Clin Ther (1991) 1.06
Statistical analysis of the effects of trial, reader, and replicates on MIC determination for cefoxitin. Antimicrob Agents Chemother (1990) 1.04
Relative importance of maternal constitutional factors and glucose intolerance of pregnancy in the development of newborn macrosomia. J Matern Fetal Med (1997) 1.02
Cesarean sections in Alberta from April 1979 to March 1988. CMAJ (1991) 1.00
Physician characteristics in relation to cardiovascular drugs commonly prescribed for hypertension in Nova Scotia. Can J Clin Pharmacol (2001) 0.98
A simple model for predicting postoperative delirium in older patients undergoing elective orthopedic surgery. J Am Geriatr Soc (1995) 0.97
Effects of smoking and treatment status on periodontal bacteria: evidence that smoking influences control of periodontal bacteria at the mucosal surface of the gingival crevice. J Periodontol (2001) 0.97
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group Report. Cancer (1978) 0.96
Management of patients with suspected deep vein thrombosis in the emergency department: combining use of a clinical diagnosis model with D-dimer testing. J Emerg Med (2000) 0.94
Weight cycling: the experience of human dieters. Am J Clin Nutr (1989) 0.94
Phase II trial of doxorubicin therapy for advanced islet cell carcinoma. Cancer Treat Rep (1982) 0.94
Thrombosis in the emergency department: use of a clinical diagnosis model to safely avoid the need for urgent radiological investigation. Arch Intern Med (1999) 0.93
Serum albumin in patients on continuous ambulatory peritoneal dialysis--predictors and correlations with outcomes. J Am Soc Nephrol (1993) 0.91
The effect of dietary glutamine and dietary RNA on ileal flora, ileal histology, and bacterial translocation in mice. Nutrition (1992) 0.91
Gallbladder adenocarcinoma: prognostic significance of tumor acid mucopolysaccharide content. J Surg Oncol (1986) 0.90
Role of myocardial temperature measurement in monitoring the adequacy of myocardial protection during cardiac surgery. Ann Thorac Surg (2001) 0.89
Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma. Cancer Treat Rep (1983) 0.89
Gallbladder adenocarcinoma: the prognostic significance of histologic grade. J Surg Oncol (1987) 0.88
Cranial computed tomographic observations in multi-infarct dementia. A controlled study. Stroke (1992) 0.88
Studies in prognostic factors relating to chemotherapy for advanced gastric cancer. Cancer (1982) 0.87
A statistical evaluation of baseline and follow-up carcinoembryonic antigen in patients with resectable colorectal carcinoma. Cancer (1981) 0.87
Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group. Cancer Treat Rep (1980) 0.87
The use of ex vivo-activated memory T cells (autolymphocyte therapy) in the treatment of metastatic renal cell carcinoma: final results from a randomized, controlled, multisite study. Semin Urol (1993) 0.86
Case-control study of ocular hypertension. Arch Ophthalmol (1983) 0.86
Expression of colorectal carcinoma-associated antigens in colonic polyps. J Surg Res (1993) 0.86
The expression of colorectal carcinoma-associated antigens in the normal colonic mucosa. An immunohistochemical analysis of regional distribution. Am J Pathol (1989) 0.85
Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones". Surgery (1979) 0.85
A carcinoembryonic antigen standardization experiment for the conduct of multi-institutional clinical trials. Gastrointestinal Tumor Study Group. Cancer Treat Rep (1980) 0.85
An evaluation of the effect of aspartame on weight loss. Appetite (1988) 0.85
Use of ultrasound in a study of schistosomal periportal fibrosis in rural Zimbabwe. Acta Trop (1993) 0.84
Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer. Cancer Treat Rep (1976) 0.84
High levels of Epstein-Barr virus in the oropharynx: a predictor of disease progression in human immunodeficiency virus infection. J Med Virol (1990) 0.84
Serial levels of CA 19-9 and CEA in colonic cancer. J Clin Oncol (1986) 0.84
Endometrial biopsy in DUB. J Reprod Med (1996) 0.83
Uveal findings in patients with cutaneous melanoma. Am J Ophthalmol (1983) 0.83
Bendectin and fetal development. A study of Boston City Hospital. Am J Obstet Gynecol (1982) 0.83
CA 125 serum levels correlated with second-look operations among ovarian cancer patients. Obstet Gynecol (1986) 0.82
Low levels of maternal serum PAPP-A in early pregnancy and the risk of adverse outcomes. Prenat Diagn (2008) 0.81
Sucrase-isomaltase is an independent prognostic marker for colorectal carcinoma. Dis Colon Rectum (1995) 0.81
Phase II evaluation of diglycoaldehyde, VP-16-213, and the combination of methyl-CCNU and beta-2'-deoxythioguanosine in previously treated patients with colorectal cancer: an Eastern Cooperative Oncology Group study (EST-1275). Cancer Treat Rep (1979) 0.80
Topoisomerase II alpha expression in normal, inflammatory, and neoplastic conditions of the gastric and colonic mucosa. Mod Pathol (1997) 0.80
Cost-utility analysis of proton pump inhibitors and other gastro-protective agents for prevention of gastrointestinal complications in elderly patients taking nonselective nonsteroidal anti-inflammatory agents. Aliment Pharmacol Ther (2010) 0.80
Preoperative risk factors that predict hospital length of stay in coronary artery bypass patients > 60 years old. Circulation (1992) 0.79
Significance of the transmural diminution in regional hydrogen ion production after repeated coronary artery occlusions. Circ Res (1989) 0.79
Angioscopically directed interventions improve arm vein bypass grafts. J Vasc Surg (1993) 0.79
Determinants of the pressor effect of phenylpropanolamine in healthy subjects. JAMA (1989) 0.78
Treatment of metastatic renal cell carcinoma with autolymphocyte therapy. Low toxicity outpatient approach to adoptive immunotherapy without use of in vivo interleukin-2. Urology (1990) 0.78
The effect of a uniquely formulated diet (supplemented with arginine, RNA, and menhaden oil) on ileal flora, ileal histology, and bacterial translocation in mice. Nutrition (1992) 0.78
Comparison of enalapril and hydrochlorothiazide in mild hypertension and changes in plasma lipid concentrations during therapy. Clin Ther (1988) 0.77
A comparison of the efficacy and tolerability of enalapril and sustained-release diltiazem in mild to moderate essential hypertension. Clin Ther (1991) 0.77
Carcinoids: the prognostic effect of primary site histologic type variations. J Surg Oncol (1986) 0.77
Hematologic toxicity of cisplatin and mitomycin in combination for squamous cell carcinoma of esophagus. Am J Clin Oncol (1985) 0.77
Performance of a commercial immunoassay for detection and differentiation of periodontal marker bacteria: analysis of immunochemical performance with clinical samples. J Periodontol (2001) 0.77
Comparison of angioscopy and angiography for monitoring infrainguinal bypass vein grafts: results of a prospective randomized trial. J Vasc Surg (1993) 0.76
Stage II endometrial carcinoma: 10-year follow-up of combined radiation and surgical treatment. Gynecol Oncol (1980) 0.76
A deficit survival analysis to assess the natural history of uveal melanoma. J Chronic Dis (1984) 0.76
The fluoridation of drinking water and hip fracture hospitalization rates in two Canadian communities. Am J Public Health (1993) 0.75
Assessment of dietary intakes of cadets at the US Military Academy at West Point. J Am Coll Nutr (1996) 0.75
The scientific and clinical results of ex vivo activated T cells for metastatic renal cell carcinoma in over 500 human patients. Cell Transplant (1994) 0.75
Role of angioscopy in reoperation for the failing or failed infrainguinal vein bypass graft. Ann Vasc Surg (1994) 0.75
Correlation of early acute rejection episodes with long-term renal transplant outcome. Transplantation (1982) 0.75
Acute care hospital morbidity in the Blood Indian Band, 1984-87. Can J Public Health (1995) 0.75
Relationship between plasma glucose levels in glucose-intolerant women and newborn macrosomia. J Matern Fetal Med (1997) 0.75
Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation. J Immunol (1982) 0.75
Diagnostic utility of specific microbiological markers for periodontal diseases. J Periodontol (1998) 0.75
Effect of gum chewing on the pH of dental plaque. J Clin Dent (1992) 0.75
Using an autoregressive model to detect departures from steady states in unequally spaced tumour biomarker data. Stat Med (1992) 0.75
Comparison of the efficacy and tolerability of lisinopril and sustained-release verapamil in black patients with hypertension. Clin Ther (1991) 0.75
Periodontitis-associated marker bacteria in an urban North American patient population: application of a commercial immunoassay. J Periodontol (1998) 0.75